Top Markets
Coin of the day
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Pozycja w akcjach #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Cena akcji
$0.51647906
Kapitalizacja rynkowa
$226.16M
Zmiana (1 dzień)
5.29%
Zmiana (1 rok)
66.66%
Kraj
IN
Handel Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategoria

Cena SHUKRAPHAR z kapitalizacją rynkową B
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
SHUKRAPHAR
$0.51647906
Kapitalizacja rynkowa Shukra Pharmaceuticals Limited(SHUKRAPHAR)
Kapitalizacja rynkowa: $226.16M
Na dzień September 2026 spółka Shukra Pharmaceuticals Limited ma kapitalizację rynkową wynoszącą $226.16M. Według naszych danych, czyni to Shukra Pharmaceuticals Limited 17792nd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Shukra Pharmaceuticals Limited od 2012 do 2026
SHUKRAPHAR w porównaniu do 5 najpopularniejszych stocks
Cena za SHUKRAPHAR Aktywa B Kapitalizacja rynkowa B Wyniki
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
$12,387.64 $226.16M
$5.424T +2,398,378.70%
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
$10,906.85 $226.16M
$4.776T +2,111,671.00%
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
$9,253.26 $226.16M
$4.052T +1,791,504.75%
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
$8,429.35 $226.16M
$3.691T +1,631,979.67%
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited
$6,267.12 $226.16M
$2.744T +1,213,331.93%